Mats Lundwall

Mats Lundwall

Direttore/Membro del Consiglio presso PHASE HOLOGRAPHIC IMAGING PHI AB

76 anni

Health Technology

Commercial Services

Relazioni attive

Nome	Sesso	Età	Società collegate	Collaborazione
Jan Peter Egelberg	M	61	PHASE HOLOGRAPHIC IMAGING PHI AB	27 anni
Patrik Eschricht	M	60	PHASE HOLOGRAPHIC IMAGING PHI AB	6 anni
Lisa Bodily	F	-	PHASE HOLOGRAPHIC IMAGING PHI AB	2 anni
Leland George Foster	M	78	PHASE HOLOGRAPHIC IMAGING PHI AB	12 anni
Håkan Rosvall	M	45	PHASE HOLOGRAPHIC IMAGING PHI AB	14 anni
Petter Björquist	M	59	PHASE HOLOGRAPHIC IMAGING PHI AB	-
Mattias Lundin	M	56	PHASE HOLOGRAPHIC IMAGING PHI AB	4 anni
Jonas Bergkvist	M	53	PHASE HOLOGRAPHIC IMAGING PHI AB	7 anni
Ann Christine Egelberg	F	61	PHASE HOLOGRAPHIC IMAGING PHI AB	20 anni
Kersti Alm	F	-	PHASE HOLOGRAPHIC IMAGING PHI AB	-
Goran Dubravcic	M	45	PHASE HOLOGRAPHIC IMAGING PHI AB	1 anni

Mostra altro

Grafico relazionale

Relazione in diverse aziende

Relazioni precedenti

Nome	Sesso	Età	Società collegate	Collaborazione
Keith McCullagh	M	80	Roche Innovation Center Copenhagen A/S Roche Innovation Center Copenhagen A/S Pharmaceuticals: MajorHealth Technology Roche Innovation Center Copenhagen A/S discovers and develops drugs for the treatment of oncology, metabolic diseases, and infectious diseases. The firm manufactures a pipeline of drug candidates that act selectively on disease-related ribonucleic acid to provide patients with novel treatments for both rare and common diseases. It produces pre-clinical and clinical assets for the treatment of a range of diseases including oncology, metabolic diseases, and infectious diseases. The company was founded by Matts Lundwall and Mikael Ørum on January 1, 1998 and is headquartered in Horsholm, Denmark.	5 anni
Per Gunnar Fernström	M	74	Roche Innovation Center Copenhagen A/S Roche Innovation Center Copenhagen A/S Pharmaceuticals: MajorHealth Technology Roche Innovation Center Copenhagen A/S discovers and develops drugs for the treatment of oncology, metabolic diseases, and infectious diseases. The firm manufactures a pipeline of drug candidates that act selectively on disease-related ribonucleic acid to provide patients with novel treatments for both rare and common diseases. It produces pre-clinical and clinical assets for the treatment of a range of diseases including oncology, metabolic diseases, and infectious diseases. The company was founded by Matts Lundwall and Mikael Ørum on January 1, 1998 and is headquartered in Horsholm, Denmark.	-
Bo Lennart Bruce	M	80	Roche Innovation Center Copenhagen A/S Roche Innovation Center Copenhagen A/S Pharmaceuticals: MajorHealth Technology Roche Innovation Center Copenhagen A/S discovers and develops drugs for the treatment of oncology, metabolic diseases, and infectious diseases. The firm manufactures a pipeline of drug candidates that act selectively on disease-related ribonucleic acid to provide patients with novel treatments for both rare and common diseases. It produces pre-clinical and clinical assets for the treatment of a range of diseases including oncology, metabolic diseases, and infectious diseases. The company was founded by Matts Lundwall and Mikael Ørum on January 1, 1998 and is headquartered in Horsholm, Denmark.	-
Peter Wilden	M	67	Ferring Pharmaceuticals A/S Ferring Pharmaceuticals A/S Pharmaceuticals: MajorHealth Technology Ferring Pharmaceuticals A/S specializes in the development, production and marketing of pharmaceutical products. It offers products in the fields of urology, infertility, obstetrics, gynecology, gastroenterology and maternal health. The company is headquartered in Copenhagen, Denmark.	26 anni
Mikael Ørum	M	71	Roche Innovation Center Copenhagen A/S Roche Innovation Center Copenhagen A/S Pharmaceuticals: MajorHealth Technology Roche Innovation Center Copenhagen A/S discovers and develops drugs for the treatment of oncology, metabolic diseases, and infectious diseases. The firm manufactures a pipeline of drug candidates that act selectively on disease-related ribonucleic acid to provide patients with novel treatments for both rare and common diseases. It produces pre-clinical and clinical assets for the treatment of a range of diseases including oncology, metabolic diseases, and infectious diseases. The company was founded by Matts Lundwall and Mikael Ørum on January 1, 1998 and is headquartered in Horsholm, Denmark.	-
Johan Hyllner	M	62	PHASE HOLOGRAPHIC IMAGING PHI AB	-
Maria Hägglund Morin	F	50	PHASE HOLOGRAPHIC IMAGING PHI AB	-
Ingrid Linda Marie Neckmar	F	51	PHASE HOLOGRAPHIC IMAGING PHI AB	-
Klas Åke Thorsten Cramborn	M	75	PHASE HOLOGRAPHIC IMAGING PHI AB	9 anni
Arne Bojesson	M	73	PHASE HOLOGRAPHIC IMAGING PHI AB	-
Liselotte Nilsson	F	54	PHASE HOLOGRAPHIC IMAGING PHI AB	-
Jorgen Wittendorff	M	-	Ferring Pharmaceuticals A/S Ferring Pharmaceuticals A/S Pharmaceuticals: MajorHealth Technology Ferring Pharmaceuticals A/S specializes in the development, production and marketing of pharmaceutical products. It offers products in the fields of urology, infertility, obstetrics, gynecology, gastroenterology and maternal health. The company is headquartered in Copenhagen, Denmark.	21 anni
Charlotte Vedel	M	56	Roche Innovation Center Copenhagen A/S Roche Innovation Center Copenhagen A/S Pharmaceuticals: MajorHealth Technology Roche Innovation Center Copenhagen A/S discovers and develops drugs for the treatment of oncology, metabolic diseases, and infectious diseases. The firm manufactures a pipeline of drug candidates that act selectively on disease-related ribonucleic acid to provide patients with novel treatments for both rare and common diseases. It produces pre-clinical and clinical assets for the treatment of a range of diseases including oncology, metabolic diseases, and infectious diseases. The company was founded by Matts Lundwall and Mikael Ørum on January 1, 1998 and is headquartered in Horsholm, Denmark.	2 anni

Statistiche

Paese	Relazioni	% del totale
Svezia	17	70.83%
Danimarca	7	29.17%

Età delle relazioni

Attive

Scorse

Uomo

Donna

Amministratori

Dirigenti

Provenienza delle relazioni